Discordances between Immunofixation (IFx) and Minimal Residual Disease (MRD) Assessment with Next-Generation Flow (NGF) and Sequencing (NGS) in Patients (Pts) with Multiple Myeloma (MM): Clinical and Pathogenic Significance

被引:0
|
作者
Rodriguez, Sara
Goicoechea, Ibai
Gemenetzi, Katerina
Botta, Cirino
Agathangelidis, Andreas
Puig, Noemi
Cedena, Maria Teresa
Medina, Alejandro
Valdes-Mas, Rafael
Garces, Juan Jose
Perez, Jose J.
Burgos, Leire
Calasanz, Maria Jose
Alignani, Diego
Vilas-Zornoza, Amaia
Sarai, Sarvide
Prosper, Felipe
Martinez-Climent, Jose Angel
Orfao, Alberto
Garcia-Sanz, Ramon
Ubieto, Ana Jimenez
Lopez, Joaquin Martinez
Lahuerta, Juan Jose
Rosinol, Laura
Blade, Joan
Mateos, Maria-Victoria
Chatzidimitriou, Anastasia
San-Miguel, Jesus F.
Paiva, Bruno
机构
关键词
D O I
10.1182/blood-2020-136258
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Alejandro Medina
    Noemi Puig
    Juan Flores-Montero
    Cristina Jimenez
    M.-Eugenia Sarasquete
    María Garcia-Alvarez
    Isabel Prieto-Conde
    Carmen Chillon
    Miguel Alcoceba
    Norma C. Gutierrez
    Albert Oriol
    Laura Rosinol
    Joan Bladè
    Mercedes Gironella
    Miguel T. Hernandez
    Veronica Gonzalez-Calle
    Maria-Teresa Cedena
    Bruno Paiva
    Jesus F. San-Miguel
    Juan-Jose Lahuerta
    Maria-Victoria Mateos
    Joaquin Martinez-Lopez
    Alberto Orfao
    Marcos Gonzalez
    Ramon Garcia-Sanz
    Blood Cancer Journal, 10
  • [2] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Medina, Alejandro
    Puig, Noemi
    Flores-Montero, Juan
    Jimenez, Cristina
    Sarasquete, M. -Eugenia
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gutierrez, Norma C.
    Oriol, Albert
    Rosinol, Laura
    Blade, Joan
    Gironella, Mercedes
    Hernandez, Miguel T.
    Gonzalez-Calle, Veronica
    Cedena, Maria-Teresa
    Paiva, Bruno
    San-Miguel, Jesus F.
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Orfao, Alberto
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [3] Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma
    Wang, Qingqing
    Yao, Li
    Zhu, Mingqing
    Yan, Lingzhi
    Jin, Song
    Shang, Jingjing
    Shi, Xiaolan
    Zhai, Yingying
    Yan, Shuang
    Yao, Weiqin
    You Hongying
    Wu, Depei
    Fu, Chengcheng
    BLOOD, 2022, 140 : 7249 - 7250
  • [4] Next Generation Flow (NGF) for High Sensitive Detection of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)
    Flores-Montero, Juan A.
    Paiva, Bruno
    Sanoja-Flores, Luzalba
    Puig, Noemi
    Garcia, Omar
    Boettcher, Sebastian
    Perez-Moran, Jose J.
    Belen Vidriales, Maria
    Mateos, Maria-Victoria
    Garcia-Sanz, Ramon
    Jimenez, Cristina
    Gonzalez, Marcos
    Martinez-Lopez, Joaquin
    Consuelo Canizo, Maria
    San Miguel, Jesus
    Durie, Brian
    van Dongen, Jacques J. M.
    Orfao, Alberto
    BLOOD, 2015, 126 (23)
  • [5] Landscape of Next Generation Sequencing (NGS)-based Minimal Residual Disease (MRD) assays for Multiple Myeloma (MM) in China
    Shen, S.
    Dan, D.
    Yao, Z.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S80 - S80
  • [6] Next Generation Flow for Multiple Myeloma Minimal Residual Disease: Igh Rearrangement NGS Is Complement to the NGF
    Kim, Sung-Min
    Kim, Jung-Ah
    Jeong, Dajeong
    Yun, Jiwon
    Lim, Kyu Min
    Hwang, Sang Mee
    Yoon, Sung-Soo
    Lee, Dong Soon
    BLOOD, 2018, 132
  • [7] Prognostic implications of MRD assessment in multiple myeloma patients: comparison of Next-Generation Sequencing and Next-Generation Flow
    Medina, Alejandro
    Jimenez, Cristina
    Puig, Noemi
    Flores-Montero, Juan
    Paiva, Bruno
    Eugenia Sarasquete, M.
    Prieto-Conde, Isabel
    Garcia-Alvarez, Maria
    Chillon, Carmen
    Alcoceba, Miguel
    Gonzalez-Calle, Veronica
    Gutierrez, Norma C.
    de Arriba, Felipe
    Hernandez, Miguel T.
    Blade, Joan
    Martinez-Lopez, Joaquin
    Calasanz, Maria-Jose
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    San-Miguel, Jesus
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E47 - E47
  • [8] Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial
    Paiva, Bruno
    Puig, Noemi
    Cedena, Maria Teresa
    Cordon, Lourdes
    Vidriales, Maria-Belen
    Burgos, Leire
    Flores-Montero, Juan
    Lopez-Anglada, Lucia
    Gutierrez, Norma
    Calasanz, Maria Jose
    Martin-Ramos, Maria Luisa
    Garcia-Sanz, Ramon
    Martinez-Lopez, Joaquin
    Oriol, Albert
    Blanchard, M. Jesus
    Rios, Rafael
    Martin, Jesus
    Martinez, Rafael
    Sarra, Josep
    Hernandez, Miguel T.
    de la Rubia, Javier
    Krsnik, Isabel
    Moraleda, Jose M.
    Palomera, Luis
    Bargay, Juan
    Orfao, Alberto
    Rosinol, Laura
    Mateos, Maria-Victoria
    Lahuerta, Juan-Jose
    Blade, Joan
    San Miguel, Jesus F.
    BLOOD, 2017, 130
  • [9] Minimal Residual Disease (MRD) Analysis Using Multiparametric Flow Cytometry (MFC) and Identification of Differences in Subpopulations Using Next Generation Sequencing (NGS) in the Bone Marrow (BM) of Multiple Myeloma (MM) Patients (pts)
    Dold, Sandra M.
    Riebl, Veronika
    Wider, Dagmar
    Follo, Marie
    Mueller, Stefan J.
    Bartsch, Ingrid
    Pantic, Milena
    Miething, Cornelius
    Kiote-Schmidt, Chrissoula
    Kortuem, K. Martin
    Zlei, Mihaela
    Azab, Abdel Kareem
    Binder, Mascha
    Rawluk, Justyna
    Duyster, Justus
    Zeiser, Robert
    Waesch, Ralph
    Engelhardt, Monika
    BLOOD, 2018, 132
  • [10] Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
    Kim, Hyun-Young
    Yoo, In Young
    Lim, Dae Jin
    Kim, Hee-Jin
    Kim, Sun-Hee
    Yoon, Sang Eun
    Kim, Seok Jin
    Cho, Duck
    Kim, Kihyun
    ANNALS OF LABORATORY MEDICINE, 2022, 42 (05) : 558 - +